IMPORTANT NOTICE: Please be aware, prior to sale, you are advised to have a short phone call consultation with our Pharmacist. Automatic purchase consents the Pharmacist to give you a quick call.
Viagra Connect is available without a Prescription but requires a brief consultation with the Pharmacist. It is available in a 4 pack or an 8 pack. Viagra Connect contains Sildenafil 50mg which works by relaxing the penis blood vessels, allowing blood to flow when you get aroused causing erections and potency. Viagra Connect will only help men become erect if you are aroused. Only for adult use, men 18 years plus.
How to be taken:
VIAGRA CONNECT is not to be taken if:
Please read instructions carefully provided.
Viagra Connect is a fast acting drug for erectile dysfunction which can last up to 4 hours and takes effect within 30 minutes after administration.
Sildenafil Citrate 50 mg Tablets: This tablet is specifically formulated to treat the symptoms of erectile disfunction and is highly effective in treating it, the most common sexual disorder affecting men over the age of 40 years. Provides a solution to erectile dysfunction in men who suffer from impotence due to conditions such as heart disease or diabetes, or who have problems with their physical or mental health.
Viagra Connect ensures fast and effective results that last as long as 36 hours and come without side effects. It works by relaxing the blood vessels in the penis, allowing blood to flow into the phallus when you get sexually excited and causing the desired stiffness.
amaraLeodaviglioneViagra Connect is a drug that belongs to the class of medicines called phosphodiesterase type 5 (PDE5) inhibitors which work by relaxing the blood vessels in the penis, allowing blood to flow into the penis when you get sexually excited and causing the desired stiffness in the area
This medication works by helping to relax the blood vessels in the penis, allowing blood to flow into the penis when you get sexually excited which causes the desired erection
wileyViagra Connect contains an active ingredient which is a medicine called Sildenafil which is used to treat the signs and symptoms of erectile dysfunction (also known as impotence) such as dizziness, lightheadedness, nausea, fainting, increased heart rate, a blocked nose, a runny nose, a sore throat, a blocked andtrained nose, a runny nose and a sore throat. It helps to facilitate the flow of blood into the penis during sexual stimulation.
Viagra has been shown to cause some mild side effects. Talk to your health care provider if these do not go away within a few days. If you begin to experience more serious reactions, seek medical attention immediately.
Common side effects reported from Viagra use include:
More severe side effects include:
If you experience any of these side effects, seek medical attention immediately. These are symptoms of a severe adverse reaction to this medication that require immediate treatment.
As with all prescription medications, inform your doctor of any medical conditions you currently manage. Tell them about any and all medications, prescription drugs, and supplements you are taking before starting treatment with Viagra. Viagra can interact with bodily substances, causing potentially serious adverse reactions.
Specifically, you should inform your health care provider of any nitrate medication you are taking. Remember to mention any herbal products you use, especially St. John’s wort.
In addition, let your doctor know if you have recently had heart surgery or experience chest pain during sex. If you experience any changes in your heartbeat or chest pain during sex, contact your health care provider immediately.
asthma is a bit more extreme than that reported by some men.As with all prescription medications, inform your health care provider of any health conditions you currently manage. Tell them if you have ever had any chest pain with an anginagorithmically poor-quality blood flow.
hair lossThis condition, which is known as hair loss, affects millions of men throughout the world. It is most commonly caused by a combination of genetic and hormonal factors. The severity of hair loss can vary from 20% to 90%.
The most common underlying factor is diabetes. It can also lead to increased hair growth and eventual hair loss. Lifestyle changes can help alleviate hair loss, such as a healthy diet and regular physical activity.
If you experience hair loss with an anginagorithically poor blood flow condition, such as an anginagorithblest or a chest paingorithblest, you may have a sensitivity to certain medications. This sensitivity can lead to an increased risk of abnormal heart rhythms and potentially other conditions.
Your health care provider will assess your medical history before prescribing this medication. This assessment should include a discussion with a healthcare provider about your treatment goals, side effects, and any concerns you have about the medication.
If you experience hair loss with an anginagorithblest, you may have a condition that affects the hair follicles, such as miniaturization of hair follicles, leading to hair loss. This hair follicle may become less active or produce thinner, shorter hair. As a result, you may experience hair loss.
If you experience hair loss with a chest paingorithblest, you may have a condition that affects the heart rhythm, such as heart failure.
Your health care provider should discuss with you any concerns about using Viagra with any underlying medical conditions.
stomach painThis medication, which is used to treat headache and stomach problems, can cause stomach irritation. If you experience stomach pain, seek medical attention immediately. Gastrointestinal issues can occur without benefit while taking Viagra, such as nausea, vomiting, or diarrhea.
The symptoms of stomach upset may include stomach cramps, feeling sick, hungry, or queasiness.
If you experience chest pain, seek medical attention immediately. The pain may be caused by an allergic reaction to this medication.
Viagra can cause a severe allergic reaction in some people.
Objective:To assess the effectiveness of sildenafil (Viagra), an oral phosphodiesterase type 5 inhibitor, and sildenafil (Viagra) versus sildenafil (Nuvafil) in the treatment of erectile dysfunction in men with benign prostatic hypertrophy (BPH).
Methods:A systematic review and meta-analysis was performed to identify studies that evaluated the effectiveness of sildenafil (Viagra) and sildenafil (Nuvafil) in men with BPH. A total of 936 men were included in the study. Of these, 638 men were administered sildenafil (Viagra) and 638 men were administered sildenafil (Nuvafil) orally in the treatment of erectile dysfunction in men with BPH. Two authors independently extracted the data, and each author's data was checked for completeness. All authors were masked to the study. Two authors independently performed the analysis and decided on the final result after discussion and consensus.
Results:A total of 12 studies met the inclusion criteria and 12 were excluded. Of these studies, two were included in the review and one was included in the meta-analysis. In total, 7 studies (11.5%) were published in English, four (3.9%) in French and two (2.1%) in Chinese. In all of the studies, the patients were predominantly men with BPH, with erectile dysfunction in a minority of men with BPH. In four studies, the primary efficacy parameter was a change from baseline in the change in the BPH score (S0; P < 0.05). In two studies, the change in the S0 and P scores was statistically significant after 4 weeks of treatment and after 8 weeks of treatment, but after 10 weeks of treatment, the results were not significant. Two of the studies were excluded for the publication bias in their results. In one study, the S0 and P scores were less than 3 and 3, respectively. In the other study, the P and S scores were less than 4 and 4, respectively. One study was selected for the meta-analysis due to its small sample size, lack of blinding, and potential confounding by age and sex.
Conclusion:Sildenafil and sildenafil (Viagra) improved men's erectile function in a small number of men with BPH. The effects were similar to those seen with sildenafil (Viagra) in patients with BPH.
A meta-analysis of randomized controlled trials of sildenafil and sildenafil (Nuvafil) in the treatment of erectile dysfunction (ED) in men with benign prostatic hypertrophyStudy:Sildenafil (Viagra), an oral phosphodiesterase type 5 inhibitor, and sildenafil (Viagra) versus sildenafil (Nuvafil) in the treatment of erectile dysfunction in men with benign prostatic hypertrophy (BPH)
Key words:Viagra, sildenafil, erectile dysfunction, treatment of benign prostatic hypertrophy
A meta-analysis of randomized controlled trials of sildenafil and sildenafil (Viagra) in the treatment of erectile dysfunction in men with BPHFigure 1. A narrative summary of the meta-analysis for sildenafil (Viagra) and sildenafil (Nuvafil) in the treatment of benign prostatic hypertrophy. Copyright © 2022 Elsevier/Methos Pharma AG Ltd. All rights reserved.
A meta-analysis of randomized controlled trials of sildenafil (Viagra) and sildenafil (Nuvafil) in the treatment of erectile dysfunction in men with benign prostatic hypertrophy. A summary of the main findings of the meta-analysis for sildenafil (Viagra) and sildenafil (Nuvafil) in the treatment of erectile dysfunction in men with BPH.Viagra (Sildenafil Citrate) is a popular medication used to treat erectile dysfunction. This medication comes in the form of sildenafil citrate, which is also known as sildenafil. It works by increasing blood flow to the penis, which helps men to get and keep an erection.
However, some studies have reported that Viagra has some negative effects on the cardiovascular system, including headaches, dizziness, flushing, and nasal congestion. In this study, patients taking Viagra reported that their erectile function improved after the first four weeks of treatment.
The primary objective of this study was to determine whether the effects of Viagra on cardiovascular health were dose-dependent or dose-related. This study was designed to evaluate the cardiovascular safety of Viagra.
This was a randomized, double-blind, parallel-group, two-way, randomized, placebo-controlled, double-blind, parallel-group study. Patients taking Viagra were recruited between July 2017 and July 2018. Patients were randomly assigned to receive either a daily dose of Viagra or placebo for five days. After the first four weeks, patients were followed up for a further four weeks to assess the cardiovascular safety.
The primary endpoint was the percentage of the population that was compliant with the study protocol, as well as the frequency of adverse events.
The primary efficacy endpoint was the percentage of the population that was compliant with the study protocol. Patients with a baseline clinical event rate less than 1% were excluded from the study. Patients were excluded from the study if they: had a history of cardiac disease; had a history of stroke or myocardial infarction; had a history of priapism or any adverse reaction to Viagra; had an erection lasting more than 4 hours; had severe hepatic impairment; had a history of priapism; or had any of the following: myocardial infarction, stroke or myocardial infarction within the previous five days; hypotension; pulmonary edema or hypotension (including severe hypotension, syncope, or syncope lasting more than 5 minutes).
Stade de France Pharmacy